Found: 76
Select item for more details and to access through your institution.
RANK is a poor prognosis marker and a therapeutic target in ER‐negative postmenopausal breast cancer.
- Published in:
- EMBO Molecular Medicine, 2023, v. 15, n. 4, p. 1, doi. 10.15252/emmm.202216715
- By:
- Publication type:
- Article
A Case Series Exploration of Multi-Regional Expression Heterogeneity in Triple-Negative Breast Cancer Patients.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 21, p. 13322, doi. 10.3390/ijms232113322
- By:
- Publication type:
- Article
Centrosome amplification: a quantifiable cancer cell trait with prognostic value in solid malignancies.
- Published in:
- Cancer & Metastasis Reviews, 2021, v. 40, n. 1, p. 319, doi. 10.1007/s10555-020-09937-z
- By:
- Publication type:
- Article
The clinical significance of cyclin B1 (CCNB1) in invasive breast cancer with emphasis on its contribution to lymphovascular invasion development.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 198, n. 3, p. 423, doi. 10.1007/s10549-022-06801-2
- By:
- Publication type:
- Article
Ubiquitin-conjugating enzyme 2C (UBE2C) is a poor prognostic biomarker in invasive breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 192, n. 3, p. 529, doi. 10.1007/s10549-022-06531-5
- By:
- Publication type:
- Article
The frequency and clinical significance of DNA polymerase beta (POLβ) expression in breast ductal carcinoma in situ (DCIS).
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 190, n. 1, p. 39, doi. 10.1007/s10549-021-06357-7
- By:
- Publication type:
- Article
Oestrogen-regulated protein SLC39A6: a biomarker of good prognosis in luminal breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 3, p. 621, doi. 10.1007/s10549-021-06336-y
- By:
- Publication type:
- Article
The prognostic significance of Flap Endonuclease 1 (FEN1) in breast ductal carcinoma in situ.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 188, n. 1, p. 53, doi. 10.1007/s10549-021-06271-y
- By:
- Publication type:
- Article
Nucleolar protein 10 (NOP10) predicts poor prognosis in invasive breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 3, p. 615, doi. 10.1007/s10549-020-05999-3
- By:
- Publication type:
- Article
The prognostic significance of interferon-stimulated gene 15 (ISG15) in invasive breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 2, p. 293, doi. 10.1007/s10549-020-05955-1
- By:
- Publication type:
- Article
The prognostic significance of BMI1 expression in invasive breast cancer is dependent on its molecular subtypes.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 182, n. 3, p. 581, doi. 10.1007/s10549-020-05719-x
- By:
- Publication type:
- Article
Prognostic significance of KN motif and ankyrin repeat domains 1 (KANK1) in invasive breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 179, n. 2, p. 349, doi. 10.1007/s10549-019-05466-8
- By:
- Publication type:
- Article
Clinicopathological significance of lipocalin 2 nuclear expression in invasive breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 179, n. 3, p. 557, doi. 10.1007/s10549-019-05488-2
- By:
- Publication type:
- Article
The prognostic significance of wild-type isocitrate dehydrogenase 2 (IDH2) in breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 179, n. 1, p. 79, doi. 10.1007/s10549-019-05459-7
- By:
- Publication type:
- Article
CDC20 expression in oestrogen receptor positive breast cancer predicts poor prognosis and lack of response to endocrine therapy.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 178, n. 3, p. 535, doi. 10.1007/s10549-019-05420-8
- By:
- Publication type:
- Article
Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 174, n. 2, p. 387, doi. 10.1007/s10549-018-05085-9
- By:
- Publication type:
- Article
Kinesin family member-18A (KIF18A) is a predictive biomarker of poor benefit from endocrine therapy in early ER+ breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 173, n. 1, p. 93, doi. 10.1007/s10549-018-4978-5
- By:
- Publication type:
- Article
Breast Tumours Resembling the Tall Cell Variant of Thyroid Papillary Carcinoma: Are They Part of the Papillary Carcinoma Spectrum or a Distinct Entity?
- Published in:
- Pathobiology, 2019, v. 86, n. 2/3, p. 83, doi. 10.1159/000490416
- By:
- Publication type:
- Article
Cten promotes Epithelial–Mesenchymal Transition (EMT) in colorectal cancer through stabilisation of Src.
- Published in:
- Pathology International, 2019, v. 69, n. 7, p. 381, doi. 10.1111/pin.12811
- By:
- Publication type:
- Article
XRCC1 deficient triple negative breast cancers are sensitive to ATR, ATM and Wee1 inhibitor either alone or in combination with olaparib.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, p. 1, doi. 10.1177/1758835920974201
- By:
- Publication type:
- Article
Untangling the clinicopathological significance of MRE11-RAD50-NBS1 complex in sporadic breast cancers.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00350-5
- By:
- Publication type:
- Article
Tripartite Motif-Containing 2, a Glutamine Metabolism-Associated Protein, Predicts Poor Patient Outcome in Triple-Negative Breast Cancer Treated with Chemotherapy.
- Published in:
- Cancers, 2024, v. 16, n. 11, p. 1949, doi. 10.3390/cancers16111949
- By:
- Publication type:
- Article
Mechanistic and Clinical Evidence Supports a Key Role for Cell Division Cycle Associated 5 (CDCA5) as an Independent Predictor of Outcome in Invasive Breast Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 22, p. 5643, doi. 10.3390/cancers14225643
- By:
- Publication type:
- Article
The METTL3 RNA Methyltransferase Regulates Transcriptional Networks in Prostate Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 20, p. 5148, doi. 10.3390/cancers14205148
- By:
- Publication type:
- Article
The Biological and Clinical Significance of Glutaminase in Luminal Breast Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 16, p. 3963, doi. 10.3390/cancers13163963
- By:
- Publication type:
- Article
FEN1 Blockade for Platinum Chemo-Sensitization and Synthetic Lethality in Epithelial Ovarian Cancers.
- Published in:
- Cancers, 2021, v. 13, n. 8, p. 1866, doi. 10.3390/cancers13081866
- By:
- Publication type:
- Article
The ITIM-Containing Receptor: Leukocyte-Associated Immunoglobulin-Like Receptor-1 (LAIR-1) Modulates Immune Response and Confers Poor Prognosis in Invasive Breast Carcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 1, p. 80, doi. 10.3390/cancers13010080
- By:
- Publication type:
- Article
A whole slide image-based machine learning approach to predict ductal carcinoma in situ (DCIS) recurrence risk.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The role of the ALKBH5 RNA demethylase in invasive breast cancer.
- Published in:
- Discover Oncology, 2024, v. 15, n. 1, p. 1, doi. 10.1007/s12672-024-01205-8
- By:
- Publication type:
- Article
Nottingham prognostic x (NPx): a risk stratification tool in ER‐positive HER2‐negative breast cancer: a validation study.
- Published in:
- Histopathology, 2024, v. 85, n. 3, p. 468, doi. 10.1111/his.15234
- By:
- Publication type:
- Article
Characteristics and prognostic significance of polo‐like kinase‐1 (PLK1) expression in breast cancer.
- Published in:
- Histopathology, 2023, v. 83, n. 3, p. 414, doi. 10.1111/his.14960
- By:
- Publication type:
- Article
Preoperative diagnosis of ductal carcinoma in situ of the breast over a 24‐year period.
- Published in:
- Histopathology, 2023, v. 83, n. 3, p. 435, doi. 10.1111/his.14994
- By:
- Publication type:
- Article
Combined proliferation and apoptosis index provides better risk stratification in breast cancer.
- Published in:
- Histopathology, 2023, v. 82, n. 7, p. 1029, doi. 10.1111/his.14887
- By:
- Publication type:
- Article
Evaluation oncotype DX<sup>®</sup> 21‐gene recurrence score and clinicopathological parameters: a single institutional experience.
- Published in:
- Histopathology, 2023, v. 82, n. 5, p. 755, doi. 10.1111/his.14863
- By:
- Publication type:
- Article
Improving mitotic cell counting accuracy and efficiency using phosphohistone‐H3 (PHH3) antibody counterstained with haematoxylin and eosin as part of breast cancer grading.
- Published in:
- Histopathology, 2023, v. 82, n. 3, p. 393, doi. 10.1111/his.14837
- By:
- Publication type:
- Article
Ki67 assessment in invasive luminal breast cancer: a comparative study between different scoring methods.
- Published in:
- Histopathology, 2022, v. 81, n. 6, p. 786, doi. 10.1111/his.14781
- By:
- Publication type:
- Article
Refining the definition of HER2‐low class in invasive breast cancer.
- Published in:
- Histopathology, 2022, v. 81, n. 6, p. 770, doi. 10.1111/his.14780
- By:
- Publication type:
- Article
The frequency and clinical significance of centromere enumeration probe 17 alterations in human epidermal growth factor receptor 2 immunohistochemistry‐equivocal invasive breast cancer.
- Published in:
- Histopathology, 2022, v. 81, n. 4, p. 511, doi. 10.1111/his.14728
- By:
- Publication type:
- Article
Nuclear morphology in breast lesions: refining its assessment to improve diagnostic concordance.
- Published in:
- Histopathology, 2022, v. 80, n. 3, p. 515, doi. 10.1111/his.14577
- By:
- Publication type:
- Article
Visual assessment of mitotic figures in breast cancer: a comparative study between light microscopy and whole slide images.
- Published in:
- Histopathology, 2021, v. 79, n. 6, p. 913, doi. 10.1111/his.14543
- By:
- Publication type:
- Article
Assessment of proliferation in breast cancer: cell cycle or mitosis? An observational study.
- Published in:
- Histopathology, 2021, v. 79, n. 6, p. 1087, doi. 10.1111/his.14542
- By:
- Publication type:
- Article
Diagnostic concordance of phyllodes tumour of the breast.
- Published in:
- Histopathology, 2021, v. 79, n. 4, p. 607, doi. 10.1111/his.14397
- By:
- Publication type:
- Article
Visual histological assessment of morphological features reflects the underlying molecular profile in invasive breast cancer: a morphomolecular study.
- Published in:
- Histopathology, 2020, v. 77, n. 4, p. 631, doi. 10.1111/his.14199
- By:
- Publication type:
- Article
The prognostic significance of ALDH1A1 expression in early invasive breast cancer.
- Published in:
- Histopathology, 2020, v. 77, n. 3, p. 437, doi. 10.1111/his.14129
- By:
- Publication type:
- Article
Immunohistochemical assessment of HRAS Q61R mutations in breast adenomyoepitheliomas.
- Published in:
- Histopathology, 2020, v. 76, n. 6, p. 865, doi. 10.1111/his.14057
- By:
- Publication type:
- Article
Prognostic significance of nucleolar assessment in invasive breast cancer.
- Published in:
- Histopathology, 2020, v. 76, n. 5, p. 671, doi. 10.1111/his.14036
- By:
- Publication type:
- Article
The prognostic significance of lysosomal protective protein (cathepsin A) in breast ductal carcinoma in situ.
- Published in:
- Histopathology, 2019, v. 74, n. 7, p. 1025, doi. 10.1111/his.13835
- By:
- Publication type:
- Article
Impact of breast cancer grade discordance on prediction of outcome.
- Published in:
- Histopathology, 2018, v. 73, n. 6, p. 904, doi. 10.1111/his.13709
- By:
- Publication type:
- Article
Heterogeneity of tumour‐infiltrating lymphocytes in breast cancer and its prognostic significance.
- Published in:
- Histopathology, 2018, v. 73, n. 6, p. 887, doi. 10.1111/his.13695
- By:
- Publication type:
- Article
Invasion in breast lesions: the role of the epithelial–stroma barrier.
- Published in:
- Histopathology, 2018, v. 72, n. 7, p. 1075, doi. 10.1111/his.13446
- By:
- Publication type:
- Article